# Subcutaneous Botulinum Toxin for Cutaneous Allodynia

> **NCT00725322** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 84 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Botulinum Toxin A
- **DRUG:** Placebo - Saline

## Key facts

- **NCT ID:** NCT00725322
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2017-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725322, "Subcutaneous Botulinum Toxin for Cutaneous Allodynia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00725322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*